Skip to content
Institutional Investor early-stage (preclinical seed Series A) late-stage (clinical development Series B and later) all stages of development Est. 2016

Medicxi

Early-stage life science focused VC firm investing in geographies such as Europe and the US

📍 London, United Kingdom

About This Fund

Medicxi is an early-stage centric venture capital investment company. Invests in geographies like Europe and the US. Typically invests in life science startups operating in sectors such as Therapeutics, Biopharma, Diagnostics and Medical Devices. Top investments include Genmab, Acutus Medical, Versartis, CoMentis.

Investment Focus

Sectors
life sciences biotech therapeutics biopharmaceuticals
Stages
early-stage (preclinical seed Series A) late-stage (clinical development Series B and later) all stages of development
Check Size $5.7M-$25.2M first ticket, larger follow-ons (e.g. $100M+ rounds)
Geography
USA Europe

What They Look For

asset-centric biotech companies with clear product vision addressing unmet medical needs; Europe and US focus; strong clinical rationale

Preparing to pitch Medicxi?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →